Planned sale

Merck (MRK): Officer filed to sell ~$8.61M

RICHARD ROBERT DELUCA JR, Officer at Merck, filed to sell ~$8.61M of Merck shares.

~$8.61M
planned to sell · 58K shares, around Nov 12, 2026
Planned for
Nov 12, 2026
Notice filed
Nov 12, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 14, 2026Federal contract · $1.6M obligatedDepartment of Health and Human Services awarded Merck: $1.63M obligated to date
  2. Sep 21, 2026FDAFDA drug approval: Winrevair
  3. Sep 24, 2026FDAFDA drug approval: Welireg
  4. Sep 24, 2026Federal contract · $21K obligatedDepartment of Veterans Affairs awarded Merck: $21K obligated to date
  5. Sep 24, 2026CongressDisclosed partial sale of MRK — reported range $1,001 - $15,000
  6. Oct 9, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“(d) Incorporated by reference is a press release issued by Merck & Co., Inc. (the “Company”) on October 13, 2026, attached as Exhibit 99.1, announcing the election of Paul J. Diaz to the Company’s Board of Directors (the “Board”), effective November 1, 2026.”
  7. Oct 14, 2026FDAFDA drug approval: Enflonsia
  8. Oct 16, 2026FDAFDA drug approval: Keytruda
  9. Oct 16, 2026FDAFDA drug approval: Keytruda Qlex
  10. Oct 29, 2026Company filing · Form 8-K · ResultsReported its results
View the official recordSEC Form 144

How to read SEC Form 144

Form 144 is a notice that a company insider plans to sell shares. It is filed when the sell order is placed, so it announces a planned sale and does not prove that the sale took place.

Full guide: What is an SEC Form 144?

What else is on file for Merck

For Merck, OQRO holds 2 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports, 4 fund holdings reports (13F) and 2 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MRK page.

How this filing works

Explore the data

Other disclosures at Merck

Everything OQRO holds on this company is on its MRK page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data